Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Apr;10(2):144-146.
doi: 10.14740/gr812w. Epub 2017 Apr 19.

Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy

Molham Abdulsamad  1 , Pavithra Reddy  1 , Suvarna Guvvala  1 , Anil Dev  1
Affiliations
Case Reports

Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy

Molham Abdulsamad et al. Gastroenterology Res. 2017 Apr.

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines the use of endoscopy and fluoroscopy to diagnose and treat pancreaticobiliary disorders. The risks of ERCP include pancreatitis, infection, bleeding and perforation. Bleeding during ERCP typically develops after sphincterotomy, hence patients should be screened and tested for coagulopathy before undergoing ERCP. Coagulopathy is a major risk factor for ERCP-related bleeding. Inherited factor VII (FVII) deficiency is a rare autosomal recessive hemorrhagic disorder that can lead to significant coagulopathy and severe bleeding if not appropriately recognized and treated preoperatively. Clinically, the disease ranges between an asymptomatic state to lethal hemorrhage and the degree of FVII deficiency does not correlate with the severity of bleeding. The use of FVII replacement therapy has been reported to prevent bleeding during surgery. We present the first report of a patient with a rare cause of coagulopathy due to inherited FVII deficiency who successfully underwent ERCP with sphincterotomy without bleeding where we used recombinant factor VIIa before and after the procedure.

Keywords: Choledocholithiasis; Coagulopathy; ERCP with sphincterotomy; NovoSeven; Recombinant factor VIIa.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endoscopic image of the ampulla while performing sphincterotomy with no bleeding.
Figure 2
Figure 2
INR level relative to rFVIIa use.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70(1):80–88. doi: 10.1016/j.gie.2008.10.039. - DOI - PubMed
    1. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP. et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–918. doi: 10.1056/NEJM199609263351301. - DOI - PubMed
    1. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104(5):1243–1252. doi: 10.1182/blood-2004-02-0595. - DOI - PubMed
    1. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K. et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93(3):481–487. doi: 10.1160/th04-10-0650. - DOI - PubMed
    1. Giansily-Blaizot M, Verdier R, Biron-Adreani C, Schved JF, Bertrand MA, Borg JY, Le Cam-Duchez V. et al. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica. 2004;89(6):704–709. - PubMed

Publication types

LinkOut - more resources